We are live on ! Find out more
Millennium Management

Millennium Management Portfolio holdings

AUM $240B
1-Year Est. Return 35.51%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Fund
S&P 500
This Quarter Est. Return
+7.92%
1 Year Est. Return
+35.51%
3 Year Est. Return
+105.02%
5 Year Est. Return
+129.21%
10 Year Est. Return
+672.54%
AUM
$203B
AUM Growth
+$28.4B
Cap. Flow
+$14B
Cap. Flow %
6.91%
Top 10 Hldgs %
26.11%
Holding
7,181
New
869
Increased
2,214
Reduced
2,337
Closed
1,192

Sector Composition

Rank Sector Weight
1 Technology 8.37%
2 Healthcare 7.45%
3 Consumer Discretionary 5.14%
4 Industrials 5.1%
5 Financials 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KYCHR
5626
DELISTED
Keyarch Acquisition Corporation Rights
KYCHR
$14.3K ﹤0.01%
100,000
GTACW
5627
CALL
DELISTED
Global Technology Acquisition Corp. I Warrant
GTACW
$14.3K ﹤0.01%
205,300
ACAQ.WS
5628
CALL
DELISTED
Athena Consumer Acquisition Corp. Redeemable warrants included as part of the units, each whole warrant exercisable for one share of Class A common stock for $11.50 per share
ACAQ.WS
$14.3K ﹤0.01%
240,000
BNAIW
5629
CALL
Brand Engagement Network Warrant
BNAIW
$1.97M
$14.1K ﹤0.01%
299,167
BDRX
5630
Biodexa Pharmaceuticals
BDRX
$133
$14K ﹤0.01%
+2
New +$35.7K
BZFDW icon
5631
CALL
BuzzFeed Inc Warrant
BZFDW
$840K
$14K ﹤0.01%
233,333
KNSW.WS
5632
CALL
DELISTED
KnightSwan Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
KNSW.WS
$14K ﹤0.01%
400,000
RGTIW icon
5633
CALL
Rigetti Computing Warrants
RGTIW
$129M
$13.8K ﹤0.01%
100,900
-750
-0.7% -$79
EBET
5634
DELISTED
EBET, INC. Common Stock
EBET
$13.8K ﹤0.01%
3,893
+1,283
+49% +$10.6K
CNEY icon
5635
CN Energy Group
CNEY
$4.58M
$13.8K ﹤0.01%
89
-86
-49% -$13.5K
VQS
5636
DELISTED
VIQ SOLUTIONS INC
VQS
$13.7K ﹤0.01%
41,484
+26,237
+172% +$7.79K
BRD.WS
5637
CALL
DELISTED
Beard Energy Transition Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
BRD.WS
$13.7K ﹤0.01%
195,000
ZPTAW
5638
CALL
DELISTED
Zapata Computing Holdings Inc. Warrant
ZPTAW
$13.5K ﹤0.01%
180,000
JWSM.WS
5639
CALL
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$13.5K ﹤0.01%
269,514
WIMI
5640
WiMi Hologram Cloud
WIMI
$22.2M
$13.4K ﹤0.01%
+1,221
New +$12.4K
CHEAW
5641
CALL
DELISTED
Chenghe Acquisition Co. Warrant
CHEAW
$13.4K ﹤0.01%
262,500
CISO
5642
CISO Global
CISO
$11.4M
$13.3K ﹤0.01%
4,990
-13,449
-73% -$44.8K
RVLP
5643
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$13.2K ﹤0.01%
23,541
-136,870
-85% -$121K
AMBI.WS
5644
CALL
DELISTED
Ambipar Emergency Response Warrants
AMBI.WS
$13.1K ﹤0.01%
26,250
TPST icon
5645
Tempest Therapeutics
TPST
$13.8M
$13.1K ﹤0.01%
795
-497
-38% -$12.5K
AEON.WS
5646
CALL
DELISTED
AEON Biopharma Inc
AEON.WS
$13.1K ﹤0.01%
145,777
TGAAW
5647
CALL
DELISTED
Target Global Acquisition I Corp. Warrant
TGAAW
$13.1K ﹤0.01%
163,833
CLDI.WS
5648
CALL
DELISTED
Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS
$13.1K ﹤0.01%
100,500
MVLAW
5649
CALL
DELISTED
Movella Holdings Inc. Warrant
MVLAW
$13.1K ﹤0.01%
115,600
LVROW
5650
CALL
DELISTED
Lavoro Ltd Warrant
LVROW
$12.6K ﹤0.01%
16,841

Similar funds

Millennium Management's Q2 2023 Portfolio in Review

As of Q2 2023, Millennium Management held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Millennium Management deployed $14B of net new capital in Q2 2023, opening 869 new positions and adding to 2,214 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.

By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.

  • Millennium Management's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
  • Millennium Management added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
  • Millennium Management's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
  • Millennium Management fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
  • Millennium Management's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
  • Millennium Management opened 869 new positions and closed 1,192 in Q2 2023.
  • Millennium Management's portfolio value rose 16% quarter-over-quarter to $203B.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.